These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18759321)

  • 1. Prevention of murine antiphospholipid syndrome by BAFF blockade.
    Kahn P; Ramanujam M; Bethunaickan R; Huang W; Tao H; Madaio MP; Factor SM; Davidson A
    Arthritis Rheum; 2008 Sep; 58(9):2824-34. PubMed ID: 18759321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice.
    Ramanujam M; Bethunaickan R; Huang W; Tao H; Madaio MP; Davidson A
    Arthritis Rheum; 2010 May; 62(5):1457-68. PubMed ID: 20131293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.
    Ramanujam M; Kahn P; Huang W; Tao H; Madaio MP; Factor SM; Davidson A
    Arthritis Rheum; 2009 Apr; 60(4):1096-101. PubMed ID: 19333924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
    Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
    Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection.
    Borhis G; Trovato M; Ibrahim HM; Isnard S; Le Grand R; Bosquet N; Richard Y
    Front Immunol; 2020; 11():252. PubMed ID: 32194549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice.
    Scapini P; Hu Y; Chu CL; Migone TS; Defranco AL; Cassatella MA; Lowell CA
    J Exp Med; 2010 Aug; 207(8):1757-73. PubMed ID: 20624892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
    Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
    J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the B cell receptor repertoire and self-reactivity by BAFF.
    Ota M; Duong BH; Torkamani A; Doyle CM; Gavin AL; Ota T; Nemazee D
    J Immunol; 2010 Oct; 185(7):4128-36. PubMed ID: 20817867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
    Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
    J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.
    Jacob CO; Yu N; Sindhava V; Cancro MP; Pawar RD; Putterman C; Stohl W
    Arthritis Rheumatol; 2015 Sep; 67(9):2523-35. PubMed ID: 25989238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia.
    Zhu XJ; Shi Y; Peng J; Guo CS; Shan NN; Qin P; Ji XB; Hou M
    Blood; 2009 Dec; 114(26):5362-7. PubMed ID: 19794139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice.
    Coquery CM; Wade NS; Loo WM; Kinchen JM; Cox KM; Jiang C; Tung KS; Erickson LD
    PLoS One; 2014; 9(7):e102284. PubMed ID: 25010693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
    Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
    Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
    Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
    Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.
    Lepse N; Land J; Rutgers A; Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Rheumatology (Oxford); 2016 Jan; 55(1):162-72. PubMed ID: 26320128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.
    Wang W; Rangel-Moreno J; Owen T; Barnard J; Nevarez S; Ichikawa HT; Anolik JH
    J Immunol; 2014 Apr; 192(7):3011-20. PubMed ID: 24574498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.